Vesugen caps #60

Indications

Microcirculation disorders; dyscirculatory encephalopathy; acute cerebral circulation disorders; vegetative-vascular dystonia; hypercholesterolemia.
The course lasts 10-30 days (1-2 packs).
 
Developed by the St. PETERSBURG Institute of Bioregulation and gerontology on the technology patented by Havinson V. H. peptide bioregulator of vessels.

Recommended

- in General and cerebral atherosclerosis
- coronary heart disease
- with hypertension
- in Endarteritis
- systemic and local microcirculation disorders
- in dyscirculatory encephalopathy
- with the consequences of acute cerebrovascular accident
- with vegetative-vascular dystonia
- in the treatment of hypercholesterolemia
- with varicose veins of the lower extremities
- when psycho-emotional stress
- under the influence on an organism of various extreme factors
- for the prevention of vascular diseases in the elderly and senile age.

Method of application

Adults take 1-2 capsules 1-2 times a day with meals. Duration of administration 10-30 days. It is advisable to repeat the course after 4-6 months.

Contraindications: individual intolerance of components, pregnancy, breast-feeding.

Side effects when using Vesugen not revealed.

Store in a dry, dark place at room temperature.

Composition

Peptide complex as-2-(lysine, glutamic acid, aspartic acid). Excipients: microcrystalline cellulose (E460), beet sugar, lactose, starch, twin-80. As an additional source of peptides.

Contraindications

Individual intolerance of components, pregnancy, breast-feeding. It is recommended to consult a doctor before use.

Description

Vesugen is a peptide complex containing amino acids that contribute to the normalization of the functional state of blood vessels.

The clinical study established the effectiveness of Vesugen in the comprehensive prevention and treatment of patients suffering from atherosclerosis of the heart, brain and lower extremities, microcirculation disorders in various organs and tissues, psychoemotional stress, as well as for the prevention of vascular diseases in the elderly and senile age.

It is possible to use Vesugen to improve blood supply in various tissues when taking other drugs to improve the effectiveness of treatment.

Vesugen is recommended to take 1-2 capsules 1-2 times a day with meals. The length of treatment is 20-30 days. It is advisable to repeat the course after 4-6 months.

The clinical study of Vesugen involved 87 patients with atherosclerosis of vessels, 53 of whom were the main group (33 men, 20 women) - they were additionally prescribed Vesugen orally during meals 1-2 capsules 1-2 times a day for 20-30 days, depending on the severity of the pathological process. 34 patients (18 men, 16 women) included in the control group were prescribed only conventional drugs. The age of patients of both groups ranged from 50 to 82 years.

Patients of both groups had different clinical manifestations of atherosclerosis depending on the lesion of vessels of different calibers: hypertension, coronary heart disease with coronary artery disease, cerebrovascular disorders with impaired memory, concentration, affective lability in patients suffering from atherosclerosis of cerebral vessels. All patients showed progressive dynamics of disease development. All patients previously received symptomatic and pathogenetic therapy for specific clinical manifestations of vascular pathology. Patients ' complaints were evaluated in dynamics, General clinical study of blood and urine, biochemical study of blood was carried out. In order to study homeostasis, a blood coagulogram was determined and a Hess sample with a tourniquet was used.

It was found that the use of Vesugen in patients with atherosclerosis of the arteries contributed to the improvement of overall health, normalization of sleep, especially in patients with cerebrovascular disorders. Patients with coronary heart disease noted a decrease in the manifestations of cardiac arrhythmias, a decrease in angina attacks. Patients with hypertension associated normalization of blood pressure with the use of Vesugen in combination with antihypertensive agents, as it was possible to achieve long-term remission between hypertensive crises with a lower dose of conventional antihypertensive agents.

As can be seen from the table, the use of Vesugen contributed to a significant decrease in the level of total cholesterol in the blood.

There was also a tendency to decrease the content of very low density lipoproteins, which are the most atherogenic.

Thus, the results of the study indicate the therapeutic efficacy of Vesugen and the feasibility of its use in the comprehensive prevention and treatment of atherosclerosis.